Michael Richman
Insider Reports History
- Location
- Houston, TX
- Signature
- /s/ Steven P. Cobourn, as attorney-in-fact for Michael Richman
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Michael Richman:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 40,000 | 21 Jun 2023 | Direct | ||
| NextCure, Inc. | President & CEO, Director | Employee Stock Option (Right to Buy) | 38,190 | 30 Jan 2026 | Direct |
Insider Reports Filed by Michael Richman
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NXTC | NextCure, Inc. | 30 Jan 2026 | 1 | $0 | 4 | President & CEO, Director | 03 Feb 2026, 16:07 |
| NXTC | NextCure, Inc. | 31 Jan 2025 | 1 | $0 | 4 | President & CEO, Director | 03 Feb 2025, 18:22 |
| NXTC | NextCure, Inc. | 29 Mar 2024 | 1 | $0 | 4 | President & CEO, Director | 02 Apr 2024, 16:44 |
| NXTC | NextCure, Inc. | 31 Jan 2024 | 1 | $0 | 4 | President & CEO, Director | 01 Feb 2024, 16:45 |
| PVLA | PIERIS PHARMACEUTICALS, INC. | 21 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 16:45 |
| NXTC | NextCure, Inc. | 28 Feb 2023 | 1 | $0 | 4 | President & CEO, Director | 01 Mar 2023, 17:01 |
| PVLA | PIERIS PHARMACEUTICALS, INC. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 19:02 |
| NXTC | NextCure, Inc. | 31 Jan 2022 | 1 | $0 | 4 | President & CEO, Director | 02 Feb 2022, 15:18 |
| PVLA | PIERIS PHARMACEUTICALS, INC. | 25 Jun 2021 | 1 | $0 | 4 | Director | 29 Jun 2021, 17:33 |